Project description
Shedding light on new germicidal technology
Antimicrobial resistance (AMR) is the ability of microorganisms to resist antimicrobial treatments, especially antibiotics. AMR is responsible for an estimated 33 000 deaths per year in the EU. It is also estimated that AMR amounts to EUR 1.5 billion per year in healthcare costs and productivity losses. According to the EU-funded ULIGHT project, there is a need to develop new technologies to target pathogens without antibiotics. One such technology involves the germicidal properties of ultraviolet light from lamps. It has been shown that short wavelength deep ultraviolet light (DUVL), such as 207 nm, can kill germs while limiting mutagenic effects. The aim of this project is to provide compact, robust, bright and low-cost DUVL sources for delivery to confined regions of the body to safely eliminate pathogens.
Objective
We will use a new class of deep ultraviolet light source to address the biggest challenge facing modern medicine: the emergence of antimicrobial resistance (AMR): the resistance of bacteria (so-called “super bugs”) to anti-biotics. AMR is anticipated to cause 10 million deaths annually by 2050. The golden era of antibiotics is over, and the antibiotic pipeline is failing. We need to develop new technologies to target pathogens without antibiotics and to which pathogens cannot develop resistance.
The germicidal properties of ultraviolet light (wavelength around 254 nm) from lamps are well established. Unfortunately, this wavelength is mutagenic to human cells and unsuitable for therapy. However, it has recently been shown that shorter-wavelength deep ultraviolet light (DUVL), such as 207 nm light, maintains germicidal efficacy while limiting mutagenic effects.
While there are existing ways to generate DUVL, they all fail to meet the constraints that must be met for ubiquitous clinical use: compact size, low cost, long lifetime, high robustness and no need for serviceability.
During my ERC Starting Grant project I developed a new route to create high brightness DUVL sources. In this project we will demonstrate the Proof of Concept of a business providing compact, robust, bright and low-cost DUVL sources—based on a down-scaling of my Starting Grant technology—for delivery to confined regions of the body for safe (non-mutagenic to human cells) killing of pathogens.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology bacteriology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance antibiotic resistance
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) ERC-2019-PoC
See all projects funded under this callHost institution
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
EH14 4AS Edinburgh
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.